| Literature DB >> 15110224 |
Irandi Jayatilleke1, Alessandra Doolan, Jodie Ingles, Mark McGuire, Virginia Booth, David R Richmond, Christopher Semsarian.
Abstract
In this study, high-risk patients with hypertrophic cardiomyopathy were treated with an implantable defibrillator. Long-term follow-up analysis showed the efficacy of implantable defibrillator therapy, with patients having an appropriate device intervention at a rate of 11%/year, thereby preventing sudden death in an Australian population.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15110224 DOI： 10.1016/j.amjcard.2004.01.057
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778